Valerio Therapeutics (FRA:C4X) Accounts Payable : €2.46 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Valerio Therapeutics Accounts Payable?

Valerio Therapeutics's Accounts Payable for the quarter that ended in Dec. 2023 was €2.46 Mil.

Valerio Therapeutics's quarterly Accounts Payable increased from Dec. 2022 (€3.45 Mil) to Jun. 2023 (€4.39 Mil) but then declined from Jun. 2023 (€4.39 Mil) to Dec. 2023 (€2.46 Mil).

Valerio Therapeutics's annual Accounts Payable increased from Dec. 2021 (€2.83 Mil) to Dec. 2022 (€3.45 Mil) but then declined from Dec. 2022 (€3.45 Mil) to Dec. 2023 (€2.46 Mil).

Valerio Therapeutics Accounts Payable Historical Data

The historical data trend for Valerio Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valerio Therapeutics Accounts Payable Chart

Valerio Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

3.67

2.76

2.83

3.45

2.46

Valerio Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															2.83	4.17	3.45	4.39	2.46

Valerio Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Valerio Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Valerio Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Valerio Therapeutics (FRA:C4X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valerio Therapeutics (FRA:C4X) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ALVIO:France

Address

49 Boulevard du General, Martial Valin, Paris, FRA, 75015

Website

https://www.valeriotx.com

Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

Valerio Therapeutics (FRA:C4X) Headlines

No Headlines